2022 annual financial data
Monopar Therapeutics 2022 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -10,536,877 USD and net income was -10,494,399 USD.
Operating cash flow was -7,228,559 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,536,877 USD
- Net income
- -10,494,399 USD
- Operating cash flow
- -7,228,559 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Monopar Therapeutics financial years